African Pharma Investment Sought to Reduce Import Reliance
Continental manufacturers have secured significant tenders, signaling a shift toward local production capacity.
Updated on Oct. 3, 2026 in Manufacturing
Live Poll
Should nations prioritize domestic manufacturing of essential products to improve long-term economic security?
John Dramani Mahama called for increased investment in African pharmaceutical manufacturing to address a dependency that currently sees the continent import over 70 percent of medicines. This push follows a successful pooled tender initiative that secured domestic production for half of the included product lines.
Why it matters
Reducing import reliance aims to curb massive foreign exchange outflows and protect domestic health systems from global supply chain volatility. With the African population projected to reach 2.5 billion by 2050, building a self-sustaining regional medical supply base is a core strategic priority.
African manufacturers secured 50 percent of product lines in the Africa CDC pooled tender, which achieved price reductions ranging from 30 to 90 percent. Currently, the continent relies on imports for 70 percent of pharmaceuticals and nearly 99 percent of vaccines.
The players
John Dramani Mahama
A political leader advocating for industrial expansion and increased investment in African pharmaceutical manufacturing capacity.
Africa CDC
The public health agency that coordinates regional pandemic preparedness and manages pooled procurement tenders for essential health products.
The details
The Africa CDC pooled tender mechanism aggregates demand from multiple countries, creating the scale necessary for local manufacturers to compete with global suppliers. By leveraging the African Continental Free Trade Area, producers can access a unified market that mitigates the cost of individual trade barriers. This approach directly challenges the existing reliance on imported goods, which exposes regional economies to significant external supply chain disruptions.
Timeline
2050: Africa's population is projected to reach 2.5 billion.
Market Landscape
This strategy follows the pattern set by the African Continental Free Trade Area, which provides the market integration necessary to support domestic pharmaceutical manufacturing. The shift marks a departure from traditional reliance on global suppliers by leveraging regional scale to lower procurement costs.
Operators in the medical and logistics sectors should monitor the expansion of regional procurement tenders as a primary driver of new supply chain opportunities. Firms currently dependent on imported medical components should evaluate whether domestic production capacity offers a lower-cost, more reliable alternative.
The takeaway
The move toward localizing production is a strategic response to the instability of long-distance supply chains. Owners should track the Africa CDC tender results as a bellwether for future government-backed manufacturing demand across the continent.
Further reading
For more on the regional industrial sector, visit our Manufacturing section.
Live Poll
Should nations prioritize domestic manufacturing of essential products to improve long-term economic security?
